Navigation Links
Innophos to Host Investor Day
Date:11/3/2011

CRANBURY, N.J., Nov. 3, 2011 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: IPHS), the leading North American producer of specialty phosphate products for the food, beverage, pharmaceutical, oral care and industrial end markets, today announced that Randy Gress, Chief Executive Officer, and other members of senior management will be hosting an investor day in New York City on November 9, 2011.  Management will be discussing the Company's position in the marketplace and growth drivers for the future.  

The meeting will take place at the Citigroup Center, 153 East 53rd Street, and is scheduled to begin at 8:30 a.m.  To access a live or replay webcast of the event, please go to www.innophos.com Investor Relations Upcoming Events. The replay will be available for one year and will begin two hours following the conclusion of the investor day.

About Innophos Holdings, Inc.Innophos is the leading North American producer of specialty phosphate products, offering performance-critical ingredients with applications in food, beverage, pharmaceutical, oral care and industrial end markets. Innophos produces complex phosphates to the highest standards of quality and consistency demanded by customers worldwide, develops new and innovative phosphate-based products to address specific customer applications and supports these high-value products with industry-leading technical service. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and San Jose de Iturbide (Mission Hills), Guanajuato (Mexico). For more information please see www.innophos.com. 'IPHS-G' IPHS-G'Contact Information:Innophos Holdings, Inc.

FTI Consulting, Inc.Investor Relations: (609) 366-1299

Alexandra Tramont/Matt Steinberginvestor.relations@innophos.com

212-850-5600
'/>"/>

SOURCE Innophos Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Innophos Holdings, Inc. Announces Acquisition of Kelatron Corporation
2. Innophos Holdings, Inc. Declares Quarterly Dividend
3. Innophos to Present at 2011 Oppenheimer Industrials Conference
4. Innophos Holdings, Inc. Declares Dividend of $0.25 Per Share; Increases Rate By 47%
5. Innophos Holdings, Inc. Announces Annual Meeting
6. Innophos Holdings, Inc. Schedules Call to Discuss Fourth Quarter and Full Year 2009 Results
7. ViroPharma to Participate in Two November Healthcare Investor Conferences
8. Vermillion Engages Liolios Group to Lead Investor Relations Program
9. Hologic to Host Investor Presentation at RSNA 2011
10. Express Scripts to Present at Investor Conferences in November
11. China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced the ... and Chief Executive Officer (CEO) and member of the Board ... Richard Love , interim President and CEO who will continue ... has over 20 years of experience in hematology, oncology and ... . "On behalf of CTI BioPharma,s Board, ...
(Date:2/24/2017)... Following receiving CE Marking in ... s AMAR is a major milestone for the country where the ... ound care market in Israel ... for inclusion in the National Health Basket , Israel ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment ...
(Date:2/24/2017)... , Feb 24, 2017 Research and Markets ... and Strategies - 2016" report to their offering. ... The latest research Dry eye Drugs Price ... the global Dry eye market. The research answers the following questions: ... Dry eye and their clinical attributes? How are they positioned in the ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... ... Guajardo Carothers is not your typical author. She went from working as a movie extra ... about God, when she isn’t swimming as a performing mermaid. , Her book isn’t typical ... she offers a comedic look at the dysfunctions of God’s family, before Lucifer was sent ...
(Date:2/27/2017)... ... ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme and Associated ... Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) dismiss any ... into a single volume a compelling argument that the disease does exist in his ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... Francisco and environs, is proud to announce an upgrade to the company's Yelp ... upgraded Yelp page on topics as diverse as Platelet Rich Plasma (PRP) therapy, ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... in staffing, scheduling, and reporting for healthcare organizations. This comprehensive and customizable ... entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects ...
Breaking Medicine News(10 mins):